International Liability for Damages Arising from the Risks of Scientific Development (COVID-19 Vaccines as an Example)
Abstract
The COVID-19 pandemic has prompted pharmaceutical companies to rapidly develop and produce vaccines and treatments to limit or prevent the virus's spread. This unprecedented scientific race has brought about numerous legal issues, particularly concerning the regulatory processes for approving these products by health authorities and specialized agencies. Some entities issued emergency use authorizations without completing the full duration of clinical trials, raising questions about the legality of these approvals and their implications for legal liability in the event of subsequent harm.
This situation introduces a crucial question regarding international liability for damages resulting from the risks associated with these scientific developments, especially concerning COVID-19 vaccines. The significance of this issue is underscored by the potential for long-term negative health effects that were not known or apparent at the time of approval. This raises legal inquiries about the nature of these risks and whether they justify an exemption from international liability, particularly if it is determined that the producing entities or authorizing countries complied with the scientific standards that were available at that time.
Keywords:
International liability, developmentrisks,vaccines,COVID-19pandemic, compensation
How to Cite
Malak Abdullah Ehmeed. (2025). International Liability for Damages Arising from the Risks of Scientific Development (COVID-19 Vaccines as an Example). مجلة الحق للعلوم الشرعية والقانونية, 251-268. https://doi.org/10.58916/alhaq.vi.296
Issue
Section
Articles
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
1.
The Holy Qur'an, Libyan Endowments House, Qaloon's Narration on the authority of Nafi', Fourteenth Edition, 2017
2.
First: Books:
3.
A- Arabic References:
4.
Amal Al-Bakoush, Objective Liability for Medical Consequences: A Study in Comparative Algerian Law, Dar Al-Jami'a Al-Jadida, Alexandria, 2017
5.
Badr Osama Ahmed, Guaranteeing the Risks of Medical Products, Dar Al-Kotob Al-Qanuniya for Publishing, Cairo, 2008
6.
Abdel Hamid Al-Dasiti Abdel Hamid, Consumer Protection in Light of the Legal Rules of Product Liability, Dar Al-Fikra Wal-Qanun, Egypt, 2009
7.
Abdel Wahid Karam, Dictionary of Legal Terms, Dar Al-Thaqafa for Publishing, Amman, Second Edition, 1998
8.
Salem Muhammad Rad'an Al-Farady, Product Liability in Civil Laws and International Agreements, Dar Al-Thaqafa Al-Arabiya for Publishing and Distribution, First Edition, 2009
9.
Muhammad Muhyi Al-Din Ibrahim Salim, As a Reason for Exempting the Producer from Liability, Dar Al-Nahda Al-Arabiya Cairo, 2007
10.
Mona Kamel Turki, Human Rights and the Humanitarian Emergency in Light of the COVID-19 Pandemic, Dar Al Nahda Al Arabiya, Egypt, First Edition, 2021
11.
B- Foreign References
12.
1. A. Ibtisam Hassan Salem Bin Issa. (2025). Medical Error Obligating Criminal Liability. Al-Haq Journal of Sharia and Legal Sciences, 1-12. https://doi.org/10.58916/alhaq.vi.275
13.
Dr. JAMA Cardiology, Patients with Acute Myocardial Infarction Following MRN COVID-19 Vaccination, American Journal of Clinical Psychology, Vol. 10, No. 6, pages 1196-1201, 2021
14.
WHO, Covax, Working for Global Equitable Access to COVID-19 Vaccines, 2020
15.
Second: Research, Journals, and Scientific Articles
16.
Ibrahim Ali Hammadi, Professional Error and Ordinary Error in the Framework of Medical Liability: A Comparative Study, Al-Halabi Legal Publications, Beirut, 2007.
17.
Lamjali Ahmed, Producer Liability for Defective Products in Jordanian Law, A Legal Analysis Comparative to French Law, Al-Ijtihad Journal of Legal Studies, Vol. 9, No. 3, 2020
18.
Ayoub Fellaq, Producer Liability for the Risks of Scientific Development in Light of the Law: A Comparative Study, University Center, Algeria.
19.
Alaa El-Din Muhammad Abu Aqil, "State Liability for Damages Arising from the Risks of Scientific Development: COVID-19 Vaccines as a Model," Journal of Jurisprudential Research, 2023, Al-Azhar University.
20.
Abdullah Hamad Al-Khalidi, "Civil Liability of Vaccine and Drug Producing Companies - Novel Coronavirus," Publishing House, Qatar University, 2021.
21.
Abdel-Raouf Ramadan Abu Sitta. (2024). Civil Liability for Medical Damages ((A Study in Libyan Law)), Al-Haq Journal of Sharia and Legal Sciences, 473-482. https://doi.org/10.58916/alhaq.vi.270
22.
Abdel Aziz Abdel-Moati Aloul, "The Extent of the State's Obligation to Compensate for Damages Arising from the COVID-19 Coronavirus," Legal Journal, 2022.
23.
Fatima Zahra Boumediene, "Product Liability for the Risks of Scientific Development in the Field of Medicine," Journal of Law and Humanities, Volume 3, Issue 9, 2014, Ziane Achour University, Algeria.
24.
Dr. Ali Abu Bakr Al-Qadimi. (2025). Administrative Responsibility of Public Health Facilities in Libyan Legislation. Al-Haq Journal of Sharia and Legal Sciences, 152-166. https://doi.org/10.58916/alhaq.vi.285
25.
Fashi Alaa, "Cases of Exclusion of Product Liability," Journal of Legal and Political Research and Studies, Issue 2, 2012, Saad University.
26.
Latifa Amazoun, "Tort Liability Provisions as a Basis for Defective Product Liability," Academic Journal of Legal Research, Issue 2, Mouloud Mammeri University, Algeria. 2018
27.
Mahmoud Ghazal and others, Responsibility for the Risks of Technological Development, Tishreen University for Scientific Research and Studies, Syria, Volume 33, Issue 1, 2011.
28.
Muhammad Mansouri and Manal Boukord, International Efforts to Combat the Novel Coronavirus, Mentouri Brothers University, Algeria, 2020.
29.
MUSBAH OMAR ALTAEB, (2020). The theory of emergency circumstances and its impact on the implementation of administrative contracts. Al-Haq Journal of Sharia and Legal Sciences, 7(1), 146-165. https://doi.org/10.58916/alhaq.vi.61
30.
Nasira Boubayya, Shahrazad Al-Wafi, and Hamza Boutghan, The Role of Big Data and Artificial Intelligence in Confronting the Coronavirus Pandemic: Successful International Experiences, Journal of Research and Human Resources Development, Volume 6, Issue 3, 2021.
31.
Siham Al-Mamar, Civil Liability for the Unexpected Harmful Effects of Vaccines, Journal of Research in Contracts and Business Law, Volume 6, Issue 1, 2021, Maghnia University Center, Algeria.
32.
Third: Theses:
33.
Mahmoud Raed Mahmoud, Civil Liability of Drug Producers for Defects in Pharmaceutical Products, Master's Thesis, Middle East University, 2011
34.
Mashael Nayef, Non-Fault Management Liability in Light of the COVID-19 Pandemic, Master's Thesis, King Abdulaziz University, Jeddah, 2022.
35.
Muhammad Issa Oud Al-Shoubaki, Civil Liability of Vaccine Producers: A Comparative Study, Master's Thesis, Middle East University, 2022.
36.
Fourth: Websites:
37.
COVAX Compensation Program 2021, https://www.covaxclaims.com, accessed March 13, 2025.
38.
British Broadcasting Corporation, 1997, https://www.bbc.com, accessed March 19, 2025.
39.
World Health Organization (WHO), 1948, https://www.who.int, accessed February 21, 2025.
40.
U.S. Centers for Disease Control and Prevention, 2022, http://www.cdc.gov, accessed February 21, 2025.
41.
French Medical Accident Compensation Office, 2022, http://www.oniam.fr, accessed March 24, 2025.
42.
United Nations (UN - Arabic version), 1995, https://www.un.org/ar/, accessed March 21, 2025
